News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
589,754 Results
Type
Article (22309)
Company Profile (321)
Press Release (567099)
Multimedia
Podcasts (116)
Webinars (20)
Section
Business (195936)
Career Advice (681)
Deals (30051)
Drug Delivery (57)
Drug Development (71672)
Employer Resources (56)
FDA (12399)
Job Trends (10810)
News (287698)
Policy (22621)
Tag
2027 BioMidwest Elite (1)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (5)
2027 Biotech Beach Elite (1)
2027 Biotech Beach Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (5)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (5)
Academia (1312)
Accelerated approval (42)
ADA (38)
Adcomms (20)
Allergies (149)
Alliances (41522)
ALS (218)
Alzheimer's disease (1530)
Antibody-drug conjugate (ADC) (530)
Approvals (12974)
Artificial intelligence (592)
ASCO (275)
Autoimmune disease (349)
Automation (41)
Bankruptcy (306)
Best Places to Work (8682)
BIO (66)
BIOSECURE Act (6)
Biosimilars (178)
BioSpace Insights (87)
Biotechnology (227)
Bladder cancer (178)
Brain cancer (64)
Breast cancer (691)
Cancer (5582)
Cardiovascular disease (429)
Career advice (589)
Career pathing (22)
CAR-T (329)
CDC (14)
Celiac Disease (1)
Cell therapy (898)
Cervical cancer (44)
Clinical research (63744)
Collaboration (2046)
Commercialization (6)
Company closure (3)
Compensation (1539)
Complete response letters (77)
COVID-19 (1495)
CRISPR (125)
C-suite (1149)
Cystic fibrosis (144)
Data (7954)
Denatured (27)
Depression (165)
Dermatology (93)
Diabetes (504)
Diagnostics (4922)
Digital health (44)
Diversity (6)
Diversity, equity & inclusion (16)
Drug discovery (354)
Drug pricing (63)
Drug shortages (6)
Duchenne muscular dystrophy (331)
Earnings (80734)
Editorial (41)
Employer branding (11)
Employer resources (52)
Events (104220)
Executive appointments (1004)
FDA (15926)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (25)
Frontotemporal dementia (35)
Funding (1660)
Gene editing (263)
Generative AI (45)
Gene therapy (729)
GLP-1 (701)
Government (1899)
Grass and pollen (4)
Guidances (337)
Healthcare (12503)
Hematology (150)
HIV (69)
Huntington's disease (63)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (106)
Immunology and inflammation (283)
Immuno-oncology (100)
Indications (206)
Infectious disease (1759)
Inflammatory bowel disease (205)
Inflation Reduction Act (12)
Influenza (97)
Intellectual property (307)
Interviews (135)
IPO (14429)
IRA (15)
Job creations (2491)
Job search strategy (496)
JPM (43)
Kidney cancer (19)
Labor market (43)
Layoffs (326)
Leadership (26)
Legal (5745)
Licensing (11)
Liver cancer (68)
Longevity (29)
Lung cancer (755)
Lymphoma (407)
Machine learning (47)
Management (17)
Manufacturing (841)
Marketing (13)
MASH (187)
Medical affairs (1)
Medical device (10063)
Medtech (10225)
Mergers & acquisitions (16834)
Metabolic disorders (1251)
mRNA (191)
Multiple sclerosis (171)
NASH (14)
Neurodegenerative disease (451)
Neuropsychiatric disorders (102)
Neuroscience (3081)
Neurotech (1)
NextGen: Class of 2026 (4340)
Non-profit (1740)
Now hiring (42)
Obesity (525)
Opinion (170)
Ovarian cancer (227)
Pain (231)
Pancreatic cancer (315)
Parkinson's disease (375)
Partnered (25)
Patents (588)
Patient recruitment (772)
Peanut (56)
People (50107)
Pharmaceutical (52)
Pharmacy benefit managers (13)
Phase 1 (20986)
Phase 2 (28746)
Phase 3 (19612)
Pipeline (9512)
Policy (125)
Postmarket research (1915)
Preclinical (8986)
Press Release (52)
Prostate cancer (293)
Psychedelics (74)
Radiopharmaceuticals (343)
Rare diseases (1121)
Real estate (3923)
Recruiting (22)
Regulatory (19703)
Reports (32)
Research institute (1390)
Resumes & cover letters (83)
Rett syndrome (49)
RNA editing (31)
RSV (58)
Schizophrenia (172)
Series A (307)
Series B (221)
Service/supplier (5)
Sickle cell disease (117)
Special edition (22)
Spinal muscular atrophy (156)
Sponsored (21)
Startups (3150)
State (1)
Stomach cancer (8)
Supply chain (73)
Tariffs (21)
The Weekly (87)
Vaccines (591)
Venture capital (107)
Weight loss (274)
Women's health (103)
Worklife (5)
Date
Today (109)
Last 7 days (598)
Last 30 days (2168)
Last 365 days (26133)
2026 (16373)
2025 (25999)
2024 (30272)
2023 (34250)
2022 (43719)
2021 (46241)
2020 (41530)
2019 (30837)
2018 (23230)
2017 (24545)
2016 (23172)
2015 (29408)
2014 (25239)
2013 (20979)
2012 (22796)
2011 (23079)
2010 (22623)
Location
Africa (382)
Alabama (92)
Alaska (3)
Arizona (337)
Arkansas (14)
Asia (29346)
Australia (4562)
California (13701)
Canada (3719)
China (1307)
Colorado (558)
Connecticut (535)
Delaware (369)
Europe (55318)
Florida (1988)
Georgia (411)
Hawaii (4)
Idaho (47)
Illinois (939)
India (81)
Indiana (457)
Iowa (17)
Japan (538)
Kansas (115)
Kentucky (37)
Louisiana (43)
Maine (37)
Maryland (1448)
Massachusetts (9902)
Michigan (318)
Minnesota (631)
Mississippi (5)
Missouri (96)
Montana (32)
Nebraska (14)
Nevada (133)
New Hampshire (77)
New Jersey (3249)
New Mexico (19)
New York (3371)
North Carolina (1670)
North Dakota (9)
Northern California (7014)
Ohio (346)
Oklahoma (15)
Oregon (36)
Pennsylvania (2670)
Puerto Rico (24)
Rhode Island (42)
South America (580)
South Carolina (78)
South Dakota (1)
Southern California (5443)
Tennessee (145)
Texas (2180)
United States (46411)
Utah (400)
Vermont (1)
Virginia (250)
Washington D.C. (52)
Washington State (1100)
West Virginia (2)
Wisconsin (107)
589,754 Results for "walking fish therapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Obesity
Kailera walks path paved by Lilly in post-IPO ‘catalyst-rich period’
Kailera Therapeutics is advancing a pipeline of weight loss medicines that mirrors Eli Lilly’s: an injectable GLP-1/GIP dual agonist like Zepbound, an oral GLP-1 like Foundayo and a triple-G therapy like retatrutide.
May 28, 2026
·
2 min read
·
Tristan Manalac
Business
Walking Fish Therapeutics Expands Leadership Team
Walking Fish Therapeutics, a leader in B cell engineering, announced the promotion of Julie Kim, PharmD, MS, to Chief Business Officer.
June 1, 2023
·
3 min read
Press Releases
Kerecis Drives the Fish-Skin Conversation at Leading European Wound Conference - EWMA-DEWU 2026
May 5, 2026
·
5 min read
Press Releases
New Clinical Data on Fish-Skin Grafts to Headline Kerecis Presence at SAWC Spring
April 8, 2026
·
6 min read
Business
MaxCyte Signs Strategic Platform License with Walking Fish Therapeutics to Support the Development of its Innovative B Cell Platform
MaxCyte, Inc. today announced the signing of a strategic platform license (SPL) with Walking Fish Therapeutics , Inc. a biotechnology company that is rapidly advancing B cell-based therapeutics.
May 4, 2023
·
3 min read
Biotech Bay
Walking Fish Therapeutics Closes $73 Million Series A Financing
Walking Fish Therapeutics , a leader in B cell therapeutics, today announced the completion of an oversubscribed Series A financing, raising a total of $73 million.
February 16, 2022
·
2 min read
Business
Walking Fish Therapeutics Expands Leadership Team and Debuts New Headquarters as it Advances Its B Cell Therapeutics Towards Clinical Trials
Walking Fish Therapeutics, a leader in B cell engineering, announced it has appointed Georgia Erbez as Chief Operating Officer and moved to a new 22,000 square foot office and world-class laboratory in South San Francisco.
September 6, 2022
·
1 min read
Press Releases
Definium Therapeutics, Inc. Announces Proposed Public Offering
June 23, 2026
·
6 min read
Press Releases
Quince Therapeutics Presents Data from Patient-Reported Walking Capacity in Children with Ataxia-Telangiectasia at 54th Child Neurology Society Annual Meeting
October 9, 2025
·
5 min read
Press Releases
St. Louis Rallies to Fund Life-Saving Research and Patient Care Services at Susan G. Komen® 2026 MORE THAN PINK Walk
March 4, 2026
·
3 min read
1 of 58,976
Next
